INDIAN IMMUNOLOGICALS (IIL) SAYS THE VIALS EXAMINED ARE NOT A PRODUCT MANUFACTURED BY HUMAN BIOLOGICALS INSTITUTE AND THAT NO MARKET COMPLAINT HAS BEEN RECEIVED IN RESPECT OF THE BATCH, ADDING THAT IT SUBMITTED ITS BATCH MANUFACTURING, QUALITY CONTROL, RECONCILIATION AND DISTRIBUTION RECORDS TO THE CDSCO ON 14.08.2026 AND HAS ASKED AUTHORITIES TO TRACE THE SOURCE OF THE VIALS AND ACT AGAINST THOSE RESPONSIBLE.
September 5, 2026 1.1K
